Ftse Mib
34.600,00
-0,65%
DAX
18.726,76
-0,21%
S&P 500
5.320,79
0,24%
NASDAQ
16.812,37
0,10%
Bitcoin
69.303,29
-3,00%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gemini Therapeutics Inc (GMTX) Gemini Therapeutics Inc (GMTX) Notizie

GMTX

Gemini Therapeutics (GMTX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GMTX
DataOraFonteTitoloSimboloCompagnia
29/06/202322:18Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:GMTXGemini Therapeutics Inc
28/06/202323:23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GMTXGemini Therapeutics Inc
21/06/202322:54Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:GMTXGemini Therapeutics Inc
20/06/202322:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GMTXGemini Therapeutics Inc
16/06/202313:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GMTXGemini Therapeutics Inc
15/06/202312:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GMTXGemini Therapeutics Inc
15/05/202313:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GMTXGemini Therapeutics Inc
20/04/202313:06Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GMTXGemini Therapeutics Inc
20/04/202313:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GMTXGemini Therapeutics Inc
31/03/202313:20Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GMTXGemini Therapeutics Inc
24/02/202322:48Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GMTXGemini Therapeutics Inc
25/01/202312:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GMTXGemini Therapeutics Inc
18/01/202312:02Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GMTXGemini Therapeutics Inc
18/01/202312:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:GMTXGemini Therapeutics Inc
09/01/202322:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GMTXGemini Therapeutics Inc
09/01/202322:03Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:GMTXGemini Therapeutics Inc
27/12/202214:56Dow Jones NewsGemini Therapeutics Shares Rise After Disc Medicine Gets FDA DesignationNASDAQ:GMTXGemini Therapeutics Inc
27/12/202214:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:GMTXGemini Therapeutics Inc
27/12/202214:00PR Newswire (US)Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic ProtoporphyriaNASDAQ:GMTXGemini Therapeutics Inc
31/10/202214:00PR Newswire (US)Disc Medicine Initiates AURORA, a Phase 2 Clinical Study of Bitopertin in Adults with Erythropoietic Protoporphyria (EPP)NASDAQ:GMTXGemini Therapeutics Inc
02/09/202223:11Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:GMTXGemini Therapeutics Inc
10/08/202213:30Business WireGemini Therapeutics and Disc Medicine Announce Merger AgreementNASDAQ:GMTXGemini Therapeutics Inc
22/07/202211:39TipRanksGemini Therapeutics (GMTX) Gets a Hold Rating from SVB SecuritiesNASDAQ:GMTXGemini Therapeutics Inc
11/03/202212:08Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:GMTXGemini Therapeutics Inc
10/03/202213:00Business WireGemini Therapeutics Reports 2021 Financial ResultsNASDAQ:GMTXGemini Therapeutics Inc
10/03/202200:16Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:GMTXGemini Therapeutics Inc
28/02/202214:37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:GMTXGemini Therapeutics Inc
28/02/202214:30Business WireGemini Therapeutics Provides Corporate UpdateNASDAQ:GMTXGemini Therapeutics Inc
04/02/202214:02Edgar (US Regulatory)Schedule 13gNASDAQ:GMTXGemini Therapeutics Inc
10/01/202214:00Business WireGemini Therapeutics Provides GEM103 Program UpdateNASDAQ:GMTXGemini Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:GMTX

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
ENI
Eni
BIT
G
Generali
BIT
SPM
Saipem
BIT
BPE
Bper Banca
BIT
STMMI
ST Microelectronics
BIT
STLAM
Stellantis NV
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
TIT
Telecom Italia
BIT
TEN
Tenaris
BIT
RACE
Ferrari NV
BIT
LDO
Leonardo
BIT
TITR
Telecom Italia
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network